Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Ying Peng Hui Kang Medical Industry Investment
Nanjing, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Nanjing Ying Peng Hui Kang Medical Industry Investment is a China-based healthcare-focused M&A and investment fund and the controlling shareholder of Global Cord Blood Corporation; it does not itself develop therapeutic products.[1][3][4][5]
- Industry
- Investors
02
Partnerships
Golden MeditechGlobal Cord Blood Corporation (formerly China Cord Blood Corporation)
Beyond the preview
Go deeper on Nanjing Ying Peng Hui Kang Medical Industry Investment.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanjing Ying Peng Hui Kang Medical Industry Investment.